The role of CD44 adhesion molecule in oral cavity cancer

Experimental Oncology

Volumn 28, Issue 2, 2006, Pages 94-98

  Georgolios, A ^a,b   Batistatou, A ^a   Charalabopoulos, A ^a,c   Manolopoulos, L ^b   Charalabopoulos, K ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Peterborough and Stamford Hospitals ^*  (United Kingdom)

Author keywords

Adhesion molecules; CD44; Head neck cancer; Oral cancer

Indexed keywords

CELL ADHESION MOLECULE; GLYCOPROTEIN; HERMES ANTIGEN; ISOPROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

CARCINOGENESIS; CELL PROLIFERATION; DRUG INHIBITION; HUMAN; MOUTH CANCER; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SALIVARY GLAND CANCER; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33746573261     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Hirano H, Screaton GR, Bell MV, Jackson DG, Bell JI, Hodes RJ. CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. Int Immunol 1994; 6: 49-59.
2. Van Weering DH, Baas PD, Bos JL. A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl 1993; 3: 100-6.
3. Day AJ, Sheehan JK. Hyaluronan: polysaccharide chaos to protein organisation. Curr Opin Struct Biol 2001; 11: 617-22.
4. Tölg C, Hofmann M, Herrlich P, Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993; 21: 1225-9.
5. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. J Clin Pathol Mol Pathol 1999; 52: 189-96.
6. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 1996; 132: 1199-208.
7. Xing R, Regezi JA, Stern M, Shuster S, Stern R. Hyaluronan and CD44 expression in minor salivary gland tumors. Oral Dis 1998; 4: 241-7.
8. Ponta H, Sherman L, Herrlich P. CD44: from adhesion molecules to signalling regulators. Mol Cell Biol 2003; 4: 33-45.
9. Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zoller J, Bosch FX, Zoller M. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 1996; 179: 66-73.
10. Kunishi M, Kayada Y, Yoshiga K. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. Int J Oral Maxillofac Surg 1997; 26: 280-3.
11. Gansauge F, Gansauge S, Rau B, Scheiblich A, Poch B, Schoenberg MH, Beger HG. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma. Cancer 1997; 80: 1733-9.
12. Ristamäki R, Joensuu H, Jalkanen S. Does soluble CD44 reflect the clinical behavior of human cancer? Curr Top Microbiol Immunol 1996; 213: 155-66.
13. Van Hal NL, Van Dongen GA, Ten Brink CB, Heider KH, Rech-Weichselbraun I, Snow GB, Brakenhoff RH. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma. Clin Cancer Res 1999; 5: 3534-41.
14. Charalabopoulos K, Mittari E, Karakosta A, Golias Ch, Batistatou A. Integrins adhesion molecules and some of their ligands in laryngeal cancer. Exp Oncol 2005; 27: 86-90.
15. Charalabopoulos K, Mittari E, Golias Ch, Peschos D, Batistatou A. Integrin receptors and extracellular matrix components in parotid neoplasms. Exp Oncol 2005; 27: 2-6.
16. Mittari E, Charalabopoulos A, Batistatou A, Charalabopoulos K. The role of cadherin/catenin complex in laryngeal cancer. Exp Oncol 2005; 27: 257-61.
17. Underhill C. CD44: the hyaluronan receptor. J Cell Sci 1992; 103: 293-8.
18. Alho AM, Underhill GB. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol 1989; 108: 1557-65.
19. Underhill C, Dorfman A. The role of hyaluronic acid in intercellular adhesion of cultured mouse cells. Exp Cell Res 1978; 117: 155-64.
20. Jalkanen S, Wu N, Bargatze RF, Butcher EC. Human lymphocyte and lymphoma homing receptors. Ann Rev Med 1987; 38: 467-76.
21. Estess P, DeGrendele HC, Pascual V, Siegelman MH. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. J Clin Invest 1998; 102: 1173-82.
22. Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe E, Soria C, Delpech B, Lu H. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer 1996; 66: 664-8.
23. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340: 1053-8.
24. Oliveira DT, Odell EW. Expression of CD44 variant exons by normal oral epithelia. Oral Oncol 1997; 33: 260-2.
25. Yu Q, Toole B. Common pattern of Cd44 isoforms is expressed in morphogenetically active epithelia. Dev Dyn 1997; 208: 1-10.
26. Sneath RJS, Mangham DC. The normal structure and function of CD44 and its role in neoplasia. Mol Pathol 1998; 51: 191-200.
27. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000; 6: 347-52.
28. Charalabopoulos K, Binolis J, Karkabounas S. Adhesion molecules in carcinogenesis. Exp Oncol 2002; 24: 249-57.
29. Piffko J, Bankfalvi A, Joos U, Ofner D, Krassort M, Schmid KW. Immunophenotypic analysis of normal mucosa and squamous cell carcinoma of the oral cavity. Cancer Detect Prev 1999; 23: 45-56.
30. Franchi A, Moroni M, Paglierani M, Santucci M. Expression of CD44 standard and variant isoforms in parotid gland and parotid gland tumours. J Oral Pathol Med 2001; 30: 564-8.
31. Reszec J, Sulkowska M, Famulski W, Guzinska-Ustymowicz K, Sulkowski S. The expression of tumorigenesis markers in oral papilloma. Pol J Pathol 2002; 53: 195-200.
32. Stoll C, Baretton G, Soost F, Terpe HJ, Domide P, Lohrs U. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol 1999; 35: 484-9.
33. Carinci F, Stabellini G, Calvitti M, Pelucchi S, Targa L, Farina A, Pezzetti F, Pastore A. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J Craniofac Surg 2002; 13: 85-9.
34. Rautava J, Soukka T, Inki P, Leimola-Virtanen R, Saloniemi I, Happonen RP, Heikinheimo K. CD44v6 in developing, dysplastic and malignant oral epithelia. Oral Oncol 2003; 39: 373-9.
35. Piffko J, Bankfalvi A, Klauke K, Dreier R, Joos U, Bocker W, Schmid KW. Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas. J Oral Pathol Med 1996; 25: 502-6.
36. Bahar R, Kunishi M, Kayada Y, Yoshiga K. CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues. Int J Oral Maxillofac Surg 1997; 26: 443-6.
37. Gonzalez-Moles MA, Bravo M, Ruiz-Avila I, Esteban F, Bascones-Martinez A, Gonzalez-Moles S. Adhesion molecule CD44 expression in non-tumour epithelium adjacent to tongue cancer. Oral Oncol 2004; 40: 281-6.
38. Ue T, Yokozaki H, Kagai K, Higashikawa K, Yasui W, Sugiyama M, Tahara E, Ishikawa T. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. J Oral Pathol Med 1998; 27: 197-201.
39. Fonseca I, Pereira T, Rosa-Santos J, Soares J. Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: A correlation with histological grade, pattern of stromal invasion, and cell differentiation. J Surg Oncol 2001; 76: 115-20.
40. Hudson DL, Speight PM, Watt FM. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. Int J Cancer 1996; 66: 457-63.
41. Sato S, Miyauchi M, Ogawa I, Kudo Y, Kitagawa S, Hiraoka M, Takata T. Inhibition of CD44v9 upregulates the invasion ability of oral squamous cell carcinoma cells. Oral Oncol 2003; 39: 27-30.
42. Sato S, Miyauchi M, Kato M, Kitajima S, Kitagawa S, Hiraoka M, Kudo Y, Ogawa I, Takata T. Unregulated CD44v9 expression inhibits the invasion of oral squamous cell carcinoma cells. Pathobiology 2004; 71: 171-5.
43. Oliveira DT, Sherriff M, Odell EW. Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas. J Oral Pathol Med 1998; 27: 303-7.